Historical record - last NADAC effective date: 11/17/2021
Product Information
CIPROFLOXACIN HCL 250 MG TAB is a generic product labeled by Yiling Pharmaceutical Inc., priced at $0.0946 per EA under NDC 69117000801. Its NADAC has been published 145 times since Feb 27, 2019.
FDA first approved this application on Jun 22, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Yiling Pharmaceutical Inc.NDC
69117000801
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
11/17/2021
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208921FDA Approved
6/22/2018
TE Code
AB
On Market Since
7/13/2019
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOXACIN HCL 250 MG TAB has been published 145 times since Feb 27, 2019, and over the history we have for it it has declined 10.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0946 per EA |
|---|---|
| All-time high | $0.1077 (Sep 15, 2021) |
| All-time low | $0.0888 (Nov 20, 2019) |
| Median price | $0.0983 |
| Average price | $0.0978 |
| Largest weekly change | +12.1% (Mar 18, 2020) |
| Weeks tracked | 145 |
| Tracking since | Feb 27, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-8.5%
All
-10.3%
Last surveyed Dec 1, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ciprofloxacin Tablets market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Yiling Pharmaceutical Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ciprofloxacin Tablets market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Fluoroquinolone Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CIPROFLOXACIN HCL 250 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACIN HCL 250 MG TAB, manufactured by Yiling Pharmaceutical Inc., is $0.0946 per EA (NDC 69117000801), effective Dec 1, 2021.
How has the price of CIPROFLOXACIN HCL 250 MG TAB changed over time?
Over the history we have for it, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has declined 10.3%. It has been tracked across 145 weekly CMS publications since Feb 27, 2019.
What are the highest and lowest recorded NADAC prices for CIPROFLOXACIN HCL 250 MG TAB?
Since Feb 27, 2019, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has ranged from a low of $0.0888 (Nov 20, 2019) to a high of $0.1077 (Sep 15, 2021), with a median of $0.0983 per EA.
Are there cheaper alternatives to CIPROFLOXACIN HCL 250 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of CIPROFLOXACIN HCL 250 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CIPROFLOXACIN HCL 250 MG TAB?
CIPROFLOXACIN HCL 250 MG TAB (NDC 69117000801) is labeled by Yiling Pharmaceutical Inc., and CMS classifies it as a generic product.